Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies

@article{Wu2011SelectiveSR,
  title={Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case–control studies},
  author={Q. Wu and A. F. Bencaz and J. Hentz and M. Crowell},
  journal={Osteoporosis International},
  year={2011},
  volume={23},
  pages={365-375}
}
  • Q. Wu, A. F. Bencaz, +1 author M. Crowell
  • Published 2011
  • Medicine
  • Osteoporosis International
  • SummaryStudies on use of selective serotonin reuptake inhibitors (SSRIs) and risk of fracture have yielded inconsistent results. This meta-analysis, which pooled results from 13 qualifying cohort and case–control studies, found that SSRIs were associated with a significantly increased risk of fractures.IntroductionThis study was conducted to assess whether people who take SSRIs are at an increased risk of fracture.MethodsWe conducted a meta-analysis of observational studies. Relevant studies… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    Antidepressant medications and osteoporosis.
    • 108

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 51 REFERENCES
    Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    • 361
    • PDF
    Measuring inconsistency in meta-analyses
    • 31,459
    • PDF
    Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
    • 293
    • Highly Influential
    • PDF